Examkin

All practice questions

4736 questions

All types4,736Multiple choice2,413Multiple select567Numeric127Matching858Ordering771
Question 3701Question →

During a routine health maintenance visit, a 48-year-old woman reports a two-year history of progressive joint pain and generalized fatigue. She casually mentions that she recently had to have her wedding band resized and was forced to purchase larger shoes. On review of systems, she notes persistent, excessive daily diaphoresis. Her blood pressure is 148/92 mmHg, and her heart rate is 76/min. Physical examination is notable for prominent supraorbital ridges, a widened jawline, and enlarged, doughy hands. Which of the following is the most appropriate initial step in laboratory evaluation?

Show answer & explanation

Answer: Measurement of serum insulin-like growth factor-1

Answer

Measurement of serum insulin-like growth factor-1
The patient's presentation of enlarged extremities, structural facial changes, hypertension, and diaphoresis is classic for acromegaly, a condition caused by a growth hormone-secreting pituitary adenoma. The initial step in the diagnostic workup is always the measurement of serum insulin-like growth factor-1 (IGF-1). Because growth hormone is secreted in a pulsatile fashion and has a short half-life, random levels are unreliable. IGF-1, which is produced by the liver in response to growth hormone, has a long half-life and accurately reflects total integrated growth hormone secretion. If the IGF-1 level is elevated, the diagnosis is subsequently confirmed with an oral glucose tolerance test demonstrating a failure to suppress growth hormone.

Step-by-Step Solution

1
Analyze the clinical vignette to identify the underlying syndrome.
The combination of acral enlargement (increased ring and shoe size), coarse facial features (prognathism, prominent ridges), diaphoresis, and secondary hypertension is highly specific for acromegaly.
Accurate syndrome recognition is required before ordering targeted diagnostic investigations.
2
Determine the standard diagnostic algorithm for suspected acromegaly.
The workup requires a highly sensitive biochemical screening test as the first step, followed by a confirmatory dynamic suppression test if the screen is abnormal.
Test sequencing must progress from non-invasive screening to definitive diagnostic confirmation.
3
Select the correct initial laboratory screening test.
Serum insulin-like growth factor-1 (IGF-1) is chosen as the initial test.
IGF-1 accurately reflects integrated growth hormone secretion over time and avoids the pitfalls of pulsatile hormone release.

Key Concept

Initial laboratory evaluation of suspected acromegaly requires measurement of serum insulin-like growth factor-1 (IGF-1).
Question 3702Question →

A 21-year-old male college student is evaluated in the emergency department for a three-week history of progressive unsteadiness and frequent falls. He also reports a constant "pins and needles" sensation in both of his hands and feet. He has no significant past medical history and takes no medications. He consumes a regular diet that includes meat, dairy, and fresh vegetables. He drinks alcohol occasionally but denies intravenous drug use. Vital signs are within normal limits. Neurologic examination reveals a spastic, broad-based gait. Vibratory and position senses are profoundly decreased in the bilateral lower and upper extremities. Deep tendon reflexes are 3+ in the patellar and Achilles tendons bilaterally, and bilateral upgoing plantar reflexes are present. Complete blood count reveals a hemoglobin of 11.0 g/dL and a mean corpuscular volume of 108 fL. Which of the following historical elements is most likely to be elicited upon further directed interviewing of this patient?

Show answer & explanation

Answer: Frequent inhalation of gas from aerosol whipped cream dispensers

Answer

The correct historical element is the frequent inhalation of gas from aerosol whipped cream dispensers, indicating nitrous oxide abuse.
The correct answer identifies recreational nitrous oxide abuse. Nitrous oxide, often inhaled from whipped cream dispensers ('whippets'), irreversibly oxidizes the cobalt atom of vitamin B12 from the 1+ to the 3+ valence state. This inactivates the vitamin and completely halts B12-dependent enzymes (methionine synthase and methylmalonyl-CoA mutase), rapidly producing a functional B12 deficiency. This leads to the classic presentation of subacute combined degeneration of the spinal cord (loss of proprioception/vibration due to dorsal column damage, and spasticity/hyperreflexia/Babinski signs due to lateral corticospinal tract damage) alongside macrocytic anemia. Eliciting this history is critical because cessation of use and immediate B12 supplementation are required to prevent irreversible neurologic damage.

Step-by-Step Solution

1
Identify the primary clinical syndrome from the examination and laboratory findings.
The patient presents with subacute combined degeneration of the spinal cord (dorsal column loss and upper motor neuron signs) accompanied by a macrocytic anemia.
This classic triad is highly specific for a severe vitamin B12 (cobalamin) deficiency.
2
Evaluate the temporal kinetics and dietary context provided in the stem.
The patient eats a regular diet and has only had symptoms for three weeks, making a purely dietary etiology highly improbable.
Dietary deficiency of vitamin B12 takes 3 to 5 years to manifest due to massive hepatic stores. The rapid onset implies acute functional depletion.
3
Synthesize demographic clues with potential toxicologic exposures that mimic this syndrome.
The patient is a college student, pointing toward recreational nitrous oxide use.
Nitrous oxide irreversibly oxidizes the cobalt core of vitamin B12, rapidly inactivating it and producing a profound functional deficiency that causes immediate neurologic damage.

Key Concept

Nitrous oxide toxicity rapidly inactivates vitamin B12, causing functional deficiency and subacute combined degeneration of the spinal cord despite adequate prior hepatic stores.
Question 3703Question →

A 32-year-old man is hospitalized for a newly diagnosed unprovoked deep vein thrombosis of the left popliteal vein. His past medical history is unremarkable, and he takes no medications. Vital signs are within normal limits. Baseline laboratory studies show a normal complete blood count, normal prothrombin time, and an activated partial thromboplastin time (aPTT) of 28 seconds (reference range: 25-35 seconds). He is started on a continuous intravenous infusion of unfractionated heparin. Twelve hours later, despite receiving two weight-based boluses and a significant increase in the continuous infusion rate, his aPTT remains at 34 seconds. Which of the following is the most likely mechanism responsible for this patient's subtherapeutic laboratory response?

Show answer & explanation

Answer: Decreased baseline activity of a serine protease inhibitor

Answer

Decreased baseline activity of a serine protease inhibitor
The correct answer identifies a deficiency in antithrombin, which is a serine protease inhibitor (serpin). Unfractionated heparin has no intrinsic anticoagulant activity; it works solely as a catalyst that binds to antithrombin, inducing a conformational change that increases antithrombin's ability to inactivate thrombin (Factor IIa), Factor Xa, and other coagulation factors by at least 1,000-fold. In a patient with an inherited or acquired antithrombin deficiency, heparin lacks its necessary cofactor. This leads to 'heparin resistance,' classically presenting as a subtherapeutic aPTT despite escalating, highly supratherapeutic doses of an unfractionated heparin infusion. The patient's unprovoked DVT at a young age was the initial manifestation of his underlying antithrombin deficiency.

Step-by-Step Solution

1
Identify the primary clinical problem in the vignette.
The patient has an unprovoked DVT and requires anticoagulation. After initiation of unfractionated heparin, his aPTT fails to rise into the therapeutic range despite escalating, high doses.
Recognizing the failure of the aPTT to prolong is the key to identifying the phenomenon of 'heparin resistance'.
2
Determine the molecular mechanism of action of unfractionated heparin.
Unfractionated heparin works by binding to antithrombin, causing a conformational change that dramatically accelerates antithrombin's ability to inactivate thrombin (Factor IIa) and Factor Xa.
Understanding the pharmacodynamics of heparin is required to understand why it might fail.
3
Correlate the mechanism of action with the clinical presentation of heparin resistance.
Because heparin relies entirely on the presence of antithrombin to function, a patient with an underlying antithrombin deficiency (a serine protease inhibitor) will not exhibit the expected anticoagulant response (prolonged aPTT) to standard or high doses of heparin.
Antithrombin deficiency perfectly explains both the patient's unprovoked DVT (as it is an inherited thrombophilia) and his subsequent heparin resistance.

Key Concept

Heparin resistance is typically caused by antithrombin deficiency. Antithrombin is a serine protease inhibitor that must be present for unfractionated heparin to exert its anticoagulant effect and prolong the aPTT.
Question 3704Question →

An emergency department physician is evaluating a 72-year-old male who presents with acute palpitations and shortness of breath. His medical history is notable for ischemic cardiomyopathy (left ventricular ejection fraction of 25%25\%) and end-stage renal disease managed with thrice-weekly hemodialysis. His routine outpatient medications include carvedilol, lisinopril, and atorvastatin. An electrocardiogram confirms atrial fibrillation with a rapid ventricular response. The patient is transferred to the cardiac intensive care unit and receives a loading dose of intravenous amiodarone, which does not adequately reduce his heart rate. The critical care team decides to initiate intravenous digoxin. Compared to a patient of identical body weight with normal renal function who is not taking amiodarone, how should the initial digoxin dosing strategy be modified for this patient?

Show answer & explanation

Answer: Decrease both the loading dose and the maintenance dose

Answer

Decrease both the loading dose and the maintenance dose
The correct strategy involves decreasing both the loading dose and the maintenance dose. The loading dose is calculated based on the drug's apparent volume of distribution (VdV_d). Digoxin binds extensively to skeletal muscle; however, in patients with end-stage renal disease, endogenous uremic substances compete for these tissue binding sites, or the affinity of the receptors decreases. This effectively reduces the VdV_d of digoxin from approximately 7 L/kg7 \text{ L/kg} to 4−5 L/kg4-5 \text{ L/kg}. To achieve the same target peak serum concentration without causing toxicity, the loading dose must be decreased. Furthermore, the maintenance dose of a drug is directly proportional to its clearance. Digoxin is primarily eliminated unchanged by the kidneys, so renal failure drastically reduces its clearance. Additionally, the patient was given amiodarone, which is a potent inhibitor of P-glycoprotein, an efflux transporter responsible for the secretion of digoxin. The concurrent use of amiodarone further decreases digoxin clearance, mandating a significant reduction in the maintenance dose.

Step-by-Step Solution

1
Analyze the patient's organ function to determine its effect on the drug's volume of distribution (VdV_d).
The patient has end-stage renal disease (ESRD), which impairs the binding of digoxin to skeletal muscle, leading to a decreased VdV_d (from ≈7 L/kg\approx 7 \text{ L/kg} to ≈4−5 L/kg\approx 4-5 \text{ L/kg}).
The loading dose of a medication is directly proportional to its VdV_d. A decreased VdV_d necessitates a proportionally lower loading dose.
2
Evaluate the impact of organ dysfunction and drug-drug interactions on the drug's clearance.
Renal failure significantly impairs digoxin excretion. Additionally, amiodarone is a potent P-glycoprotein inhibitor, which further reduces digoxin clearance by approximately 50%50\%.
The maintenance dose of a drug is directly proportional to its clearance. Severely reduced clearance requires a lower maintenance dose.
3
Synthesize these pharmacokinetic changes to formulate the final dosing strategy.
Both the loading dose and maintenance dose must be decreased compared to a patient with normal organ function not receiving amiodarone.
Decreasing the loading dose prevents initial toxicity from a contracted VdV_d, and decreasing the maintenance dose prevents delayed toxicity from impaired clearance.

Key Concept

In end-stage renal disease, the volume of distribution of digoxin decreases due to reduced tissue binding, mandating a lower loading dose. Its clearance is also substantially decreased by renal impairment and P-glycoprotein inhibitors (like amiodarone), requiring a lower maintenance dose.
Question 3705Question →

A hospital pharmacovigilance committee is reviewing a series of adverse drug events and therapeutic failures. Match each clinical presentation (left) with the underlying pharmacokinetic or pharmacodynamic mechanism most likely responsible for the outcome (right).

Click a left item, then click its matching right item

Items

Initiation of amiodarone for atrial fibrillation leads to the development of nausea, xanthopsia, and atrioventricular block in a patient previously stable on digoxin.
An unintended pregnancy occurs in a patient strictly adherent to combined oral contraceptives who recently completed a multidrug regimen for active pulmonary tuberculosis.
Escalating doses of extended-release oxycodone are required over a six-month period to maintain baseline analgesia in a patient with severe chronic radiculopathy.
Development of coarse tremors, ataxia, and confusion occurs shortly after adding chlorthalidone to the regimen of a patient with well-controlled bipolar disorder on lithium.

Matches

Show answer & explanation

Answer

Digoxin toxicity is caused by P-glycoprotein inhibition; contraceptive failure is caused by CYP3A4 induction; opioid tolerance is caused by receptor uncoupling/internalization; and lithium toxicity is caused by enhanced proximal tubule reabsorption.
Each clinical scenario corresponds to a distinct pharmacological principle. The amiodarone-digoxin interaction is a classic example of P-glycoprotein inhibition. The rifampin-oral contraceptive interaction demonstrates CYP3A4 induction, accelerating drug clearance and leading to subtherapeutic levels. Opioid tolerance exemplifies a pharmacodynamic shift at the cellular level via receptor downregulation. Finally, the thiazide-lithium interaction highlights altered renal pharmacokinetics, where induced volume depletion enhances proximal tubular reabsorption of lithium.

Step-by-Step Solution

1
Analyze the digoxin and amiodarone interaction.
Identify that amiodarone increases digoxin levels.
Amiodarone inhibits P-glycoprotein, reducing digoxin clearance.
2
Analyze the tuberculosis treatment and oral contraceptive failure.
Identify rifampin as the cause of decreased contraceptive efficacy.
Rifampin is a potent inducer of CYP450 enzymes (specifically CYP3A4), which accelerates the metabolism of estrogen.
3
Evaluate the need for escalating opioid doses over time.
Identify pharmacodynamic tolerance.
Chronic agonism of mu-opioid receptors leads to their downregulation and uncoupling from G-proteins.
4
Analyze the lithium and chlorthalidone interaction.
Identify that thiazides increase serum lithium levels.
Thiazide-induced sodium depletion causes the kidneys to compensatory increase proximal tubular reabsorption of both sodium and lithium.

Key Concept

Understanding specific drug interactions mediated by transport proteins (P-gp), metabolizing enzymes (CYP450), renal clearance mechanisms, and receptor-level pharmacodynamics is essential for preventing adverse outcomes.
Question 3706Question →

A 45-year-old man who received a deceased-donor renal allograft 6 months ago presents to the clinic with decreased visual acuity and floaters in his right eye. Funduscopic examination reveals perivascular yellowish-white retinal exudates with associated intraretinal hemorrhage. He is admitted and started on induction therapy with an appropriate intravenous antiviral agent. Three weeks later, his symptoms worsen, and laboratory testing shows a rising viral load of the causative pathogen, suggesting drug resistance. The most common mechanism of resistance for this specific antiviral agent involves a genetic mutation that prevents the initial intracellular activation of the drug. The mutated gene most likely encodes which of the following viral enzymes?

Show answer & explanation

Answer: Protein kinase

Answer

Protein kinase
Cytomegalovirus (CMV) retinitis is typically treated with ganciclovir, a guanosine analog that ultimately inhibits viral DNA synthesis. However, ganciclovir is administered as a prodrug that must first be phosphorylated into a monophosphate form within the infected cell. Unlike Herpes Simplex Virus (HSV) and Varicella-Zoster Virus (VZV), which use a viral thymidine kinase for this initial step, CMV does not encode a functional thymidine kinase. Instead, CMV utilizes a viral protein kinase encoded by the UL97 gene. The most common mechanism of ganciclovir resistance in CMV involves a genetic mutation in the UL97 gene, which directly prevents this crucial initial phosphorylation, rendering the drug inactive.

Step-by-Step Solution

1
Diagnose the opportunistic infection based on the clinical presentation.
The patient is a transplant recipient presenting with visual changes and funduscopic findings of retinal exudates with hemorrhage ('pizza pie' retinopathy), which is highly characteristic of Cytomegalovirus (CMV) retinitis.
Establishing the correct pathogen is necessary to identify the appropriate standard therapy.
2
Identify the standard first-line therapy for this infection.
The standard induction therapy for sight-threatening CMV retinitis is intravenous ganciclovir.
The question asks about the mechanism of resistance to the initial antiviral agent used.
3
Determine the intracellular activation pathway of the identified drug and the mechanism of resistance described in the stem.
Ganciclovir is a prodrug that must be phosphorylated to become active. In CMV, this first phosphorylation step is catalyzed by a viral protein kinase encoded by the UL97 gene. Mutations in this gene prevent the drug's activation.
The stem specifies a mutation preventing the 'initial intracellular activation of the drug,' isolating the activating enzyme rather than the final target.

Key Concept

Cytomegalovirus (CMV) resistance to ganciclovir most commonly occurs via mutations in the viral UL97 gene, which encodes a protein kinase responsible for the initial phosphorylation and activation of the drug.
Question 3707Question →

A 24-year-old woman comes to the clinic for evaluation of a widespread, erythematous rash on her cheeks and the sun-exposed areas of her arms. She also reports progressive joint pain and swelling in her wrists and fingers over the past 3 months. Her medical history is significant for several episodes of severe pneumococcal pneumonia and bacterial sinusitis during childhood and adolescence. Her temperature is 37.6°C (99.7°F), blood pressure is 138/88 mm Hg, and pulse is 88/min. Physical examination reveals a prominent malar rash and synovitis of the metacarpophalangeal joints bilaterally. Laboratory studies show:

TestResultReference Range
Antinuclear antibodiesPositive (1:640)Negative
Anti-double-stranded DNAPositiveNegative
Total hemolytic complement (CH50)< 10 U/mL41–90 U/mL
Alternative pathway hemolytic activity (AH50)85%> 70%

Which of the following is the most likely primary immunopathologic consequence of this patient's underlying quantitative serum defect?

Show answer & explanation

Answer: Impaired reticuloendothelial clearance of circulating immune complexes and apoptotic bodies

Answer

Impaired reticuloendothelial clearance of circulating immune complexes and apoptotic bodies
The patient's clinical presentation (early-onset SLE-like syndrome and recurrent childhood pyogenic infections) combined with an undetectable CH50 and normal AH50 indicates a primary deficiency of an early classical complement pathway component (C1q, C2, or C4). The early classical complement pathway is physiologically essential for the clearance of circulating immune complexes and apoptotic debris. During normal function, C1q binds to antibodies within immune complexes, leading to the activation of C2 and C4. This sequence covalently deposits C3b onto the immune complexes. Erythrocytes, which bear complement receptor 1 (CR1), bind these C3b-tagged complexes and transport them to the reticuloendothelial system (primarily the spleen and liver) where they are safely stripped and cleared by macrophages. A deficiency in C1, C2, or C4 halts this process, resulting in the prolonged circulation, accumulation, and eventual tissue deposition of these immune complexes. This leads directly to Type III hypersensitivity reactions manifesting as lupus nephritis, arthritis, and cutaneous lupus.

Step-by-Step Solution

1
Analyze the laboratory profile of the complement system functional assays.
The patient has an undetectable CH50 (measuring the classical and terminal pathways) but a normal AH50 (measuring the alternative and terminal pathways).
Differentiating between classical, alternative, and terminal complement pathway defects requires analyzing which pathways are non-functional. A normal AH50 rules out a terminal pathway (C5-C9) defect.
2
Synthesize the lab findings to identify the precise pathway defect.
The combination of low CH50 and normal AH50 isolates the defect exclusively to the early classical complement pathway (C1, C2, or C4).
Since the terminal pathway is intact (evidenced by normal AH50), the CH50 failure must be due to an early classical component missing.
3
Correlate the classical pathway defect with the patient's clinical presentation.
The patient has a primary deficiency of an early classical complement component (most commonly C2), which manifests clinically as an early-onset systemic lupus erythematosus (SLE)-like syndrome and susceptibility to encapsulated bacteria.
The early classical pathway is physiologically essential for tagging immune complexes and apoptotic cellular debris for removal by the reticuloendothelial system. Without it, immune complexes deposit in tissues, causing Type III hypersensitivity.

Key Concept

Early classical complement pathway deficiencies (C1, C2, C4) are characterized by an undetectable CH50 with a normal AH50, and they classically predispose patients to severe systemic lupus erythematosus due to impaired clearance of immune complexes.
Question 3708Question →

A clinical pharmacologist is reviewing medication management protocols for a hospital system. Various clinical interventions and patient-specific factors necessitate adjustments in pharmacotherapy based on underlying pharmacokinetic principles. Match each clinical scenario or intervention on the left with its most accurate expected pharmacokinetic consequence on the right.

Click a left item, then click its matching right item

Items

Initiating intermittent hemodialysis for a patient on a medication with a volume of distribution (VdV_d) of 15 L/kg15 \text{ L/kg} and 98% plasma protein binding.
Doubling the continuous intravenous infusion rate of a medication that exhibits strict first-order elimination kinetics.
Converting a medication known to undergo extensive hepatic first-pass metabolism from an oral formulation to a sublingual formulation.
Increasing the daily maintenance dose by 20% for a medication that strictly follows zero-order (capacity-limited) elimination kinetics.

Matches

Show answer & explanation

Answer

The clinical interventions dictate specific pharmacokinetic outcomes: high VdV_d and high protein binding preclude hemodialysis clearance; first-order infusions alter CssC_{ss} but not the time to steady state; sublingual dosing bypasses first-pass metabolism to increase FF; and zero-order drugs accumulate disproportionately with any dose increases.
Each clinical scenario strictly aligns with fundamental pharmacokinetic rules. High volume of distribution and extensive protein binding severely limit a drug's presence in the dialyzable plasma compartment. Sublingual dosing alters the anatomical absorption route to bypass hepatic enzymes, massively increasing bioavailability. First-order kinetics maintain a constant half-life, meaning time to steady state is unaffected by dose rate changes, whereas zero-order kinetics involve saturated enzymes that cannot accommodate dose increases proportionally.

Step-by-Step Solution

1
Analyze the effect of hemodialysis on a drug with a VdV_d of 15 L/kg15 \text{ L/kg} and 98% protein binding.
The drug is determined to be poorly dialyzable.
High VdV_d indicates extensive tissue distribution, and high protein binding keeps the small intravascular fraction trapped. Hemodialysis only effectively removes unbound, free drug present in the plasma compartment.
2
Evaluate the pharmacokinetic impact of doubling an IV infusion rate for a first-order drug.
Steady-state concentration (CssC_{ss}) doubles, but the time to CssC_{ss} is unchanged.
First-order kinetics dictate a linear relationship between infusion rate and CssC_{ss} (Css=RateClC_{ss} = \frac{\text{Rate}}{Cl}). Time to steady state depends solely on the half-life (requiring 4-5 half-lives), which does not fluctuate with dose.
3
Determine the physiological consequence of switching a high first-pass drug to sublingual administration.
Systemic bioavailability (FF) increases dramatically.
Sublingual venous drainage bypasses the portal vein, avoiding initial hepatic enzymatic degradation and allowing the full active dose to enter the systemic circulation.
4
Assess the effect of a 20% dose increase on a zero-order elimination drug.
Disproportionate, exponential increase in steady-state concentration.
Because elimination pathways are fully saturated, any additional drug administered cannot be cleared at a proportional rate, leading to non-linear and potentially toxic accumulation.

Key Concept

Clinical pharmacokinetics: dialyzability, infusion kinetics, first-pass metabolism, and capacity-limited elimination.
Question 3709Question →

A 42-year-old woman is evaluated in the pulmonary clinic for a 6-month history of progressive shortness of breath with exertion, a dry, hacking cough, and mild generalized fatigue. She also reports diffuse joint pains, particularly in her knees and wrists. She has no fever, chills, or night sweats. Medical history is notable for recurrent urinary tract infections, for which she takes prophylactic nitrofurantoin. Her surgical history includes an appendectomy at age 20. Social history reveals she smoked a half-pack of cigarettes daily for 10 years but quit 5 years ago. She currently lives with a pet parrot. Ten years ago, she relocated from the Ohio River Valley to her current city to work as a precision machinist at an aerospace manufacturing facility. Vital signs are within normal limits. Physical examination shows a few tender, violaceous nodules on her anterior shins. Lungs are clear to auscultation bilaterally. A recent chest radiograph demonstrated bilateral hilar lymphadenopathy. A subsequent transbronchial lung biopsy revealed multiple well-formed, noncaseating granulomas with no evidence of acid-fast bacilli or fungal organisms. Based on this patient's comprehensive history and preliminary evaluation, which of the following is the most appropriate next step to establish the definitive etiology?

Show answer & explanation

Answer: Peripheral blood beryllium lymphocyte proliferation test

Answer

The most appropriate next step is a peripheral blood beryllium lymphocyte proliferation test.
The correct answer is the peripheral blood beryllium lymphocyte proliferation test. This patient's presentation (dyspnea, cough, erythema nodosum, bilateral hilar lymphadenopathy, and well-formed noncaseating granulomas) strongly resembles sarcoidosis. However, her occupational history as a precision machinist in aerospace manufacturing places her at high risk for beryllium exposure. Chronic Beryllium Disease (CBD) is a granulomatous lung disease that is clinically and histologically indistinguishable from sarcoidosis. The critical differentiating step is recognizing the occupational exposure in the patient's history and ordering a beryllium lymphocyte proliferation test (BeLPT). A positive BeLPT confirms beryllium sensitization and establishes the diagnosis of CBD, which is vital because primary management involves removing the patient from further beryllium exposure.

Step-by-Step Solution

1
Analyze the clinical presentation and histological findings.
The patient presents with symptoms, imaging (bilateral hilar lymphadenopathy), skin findings (erythema nodosum), and histology (noncaseating granulomas) that are classically associated with sarcoidosis.
Establishing the baseline clinical syndrome narrows the differential diagnosis to granulomatous diseases.
2
Evaluate the medical, social, and occupational history for specific risk factors.
The history contains multiple distractors (nitrofurantoin, Ohio River Valley, pet parrot) and one critical occupational exposure: working as a precision machinist in aerospace manufacturing.
Aerospace, nuclear, and ceramics manufacturing are high-risk industries for beryllium exposure.
3
Synthesize the exposure history with the clinical syndrome.
Chronic Beryllium Disease (CBD) is clinically, radiographically, and histologically indistinguishable from sarcoidosis.
Without specific testing, CBD is frequently misdiagnosed as sarcoidosis.
4
Determine the optimal diagnostic test to differentiate the etiologies.
The beryllium lymphocyte proliferation test (BeLPT) on peripheral blood or bronchoalveolar lavage fluid is the definitive test for beryllium sensitization and CBD.
Identifying CBD is critical because, unlike sarcoidosis, management requires immediate and permanent removal of the patient from the source of beryllium exposure.

Key Concept

Chronic beryllium disease (CBD) is clinically and histologically indistinguishable from sarcoidosis (presenting with bilateral hilar adenopathy and noncaseating granulomas). Identifying a relevant occupational history (e.g., aerospace, ceramics, metal machining) is critical, and the diagnosis is confirmed via the beryllium lymphocyte proliferation test (BeLPT).
Estimated Time:1m 30s
Question 3710Question →

Match each patient's clinical presentation with the most appropriate initial targeted laboratory evaluation.

Click a left item, then click its matching right item

Items

A 45-year-old man with a 3-month history of progressive proximal muscle weakness and an erythematous rash over his metacarpophalangeal joints.
A 62-year-old woman presenting with new-onset unilateral headache, scalp tenderness, and jaw pain while chewing food.
A 28-year-old woman with treatment-resistant hypertension, unexplained hypokalemia, and a recently discovered adrenal nodule.
A 55-year-old man with new-onset erectile dysfunction, progressive fatigue, skin hyperpigmentation, and hepatomegaly.
A 32-year-old woman with episodic palpitations, paroxysmal diaphoresis, and severe headaches during acute hypertensive episodes.

Matches

Show answer & explanation

Answer

Dermatomyositis matches with creatine kinase and aldolase; Giant cell arteritis matches with ESR and CRP; Primary hyperaldosteronism matches with aldosterone-renin ratio; Hemochromatosis matches with transferrin saturation and ferritin; Pheochromocytoma matches with fractionated metanephrines.
Establishing a precise diagnosis begins with matching the patient's syndromic presentation to a focused laboratory workup. Muscle inflammation in dermatomyositis elevates creatine kinase and aldolase. Vascular inflammation in giant cell arteritis elevates ESR and CRP. Autonomous adrenal aldosterone secretion suppresses renin, resulting in an elevated aldosterone-renin ratio. Iron tissue deposition in hemochromatosis drastically increases transferrin saturation and ferritin. Finally, catecholamine-secreting tumors like pheochromocytomas elevate circulating plasma metanephrines. Ordering these specific initial tests is critical before pursuing confirmatory imaging or biopsies.

Step-by-Step Solution

1
Analyze the 45-year-old man's presentation.
Identified signs of dermatomyositis (proximal weakness, Gottron papules).
Guides the selection of muscle enzymes (creatine kinase, aldolase) for initial diagnostic workup.
2
Analyze the 62-year-old woman's presentation.
Identified classic signs of giant cell arteritis (unilateral headache, jaw claudication).
Prompts the urgent ordering of systemic inflammatory markers (ESR, CRP) to prevent ischemic complications.
3
Analyze the 28-year-old woman's presentation.
Identified symptoms suggestive of primary hyperaldosteronism (resistant hypertension, hypokalemia).
Directs the clinician to screen with the plasma aldosterone-to-renin ratio before invasive imaging.
4
Analyze the 55-year-old man's presentation.
Identified the constellation of hemochromatosis (hyperpigmentation, hepatomegaly, erectile dysfunction).
Indicates iron overload, requiring assessment of serum transferrin saturation and ferritin.
5
Analyze the 32-year-old woman's presentation.
Identified the classic triad of pheochromocytoma (episodic hypertension, palpitations, diaphoresis).
Necessitates biochemical screening with plasma fractionated free metanephrines.

Key Concept

Selecting the most appropriate initial laboratory evaluation requires identifying the underlying pathophysiologic syndrome based on classic clinical vignettes.
Question 3711Question →

A 68-year-old man with a 45-pack-year smoking history is evaluated in the hospital for worsening shortness of breath and a persistent, dry cough over the past three weeks. He reports an unintentional weight loss of 4 kg (8.8 lb) over the last month. His temperature is 37.2°C (99.0°F), blood pressure is 138/82 mmHg, pulse is 94/min, and respiratory rate is 22/min. Pulse oximetry shows 92% on room air. On physical examination of the chest, inspection reveals asymmetric chest expansion with decreased movement on the right side. Palpation demonstrates a trachea that is distinctly deviated to the right, along with markedly decreased tactile fremitus over the right anterior and posterior hemithorax. Percussion is uniformly dull over the right lung fields. Auscultation reveals absent breath sounds on the right side. Cardiac examination is unremarkable. Which of the following is the most likely diagnosis based on these physical examination findings?

Show answer & explanation

Answer: Complete endobronchial obstruction of the right mainstem bronchus

Answer

Complete endobronchial obstruction of the right mainstem bronchus
The correct answer accurately synthesizes the four key physical examination findings of massive atelectasis caused by a complete mainstem bronchus obstruction. Endobronchial obstruction (commonly due to bronchogenic carcinoma in a heavy smoker) causes resorption of air distal to the occlusion, leading to lung collapse (atelectasis). This massive volume loss pulls the mediastinum and trachea TOWARD the side of the lesion (ipsilateral deviation). The collapsed, airless lung yields dullness to percussion. Because there is no airflow into the collapsed lung and the airway is entirely obstructed, breath sounds are absent and tactile fremitus is decreased.

Step-by-Step Solution

1
Analyze the percussion and breath sound findings.
The right hemithorax exhibits dullness to percussion and absent breath sounds.
Normal air-filled lung is resonant; replacement by fluid or a collapsed airless lung causes dullness. Absent breath sounds indicate a lack of airflow reaching that region.
2
Evaluate the tactile fremitus.
Tactile fremitus is markedly decreased on the right.
Consolidation with a patent airway increases sound transmission (increased fremitus), whereas an obstructed airway or intervening pleural fluid decreases sound transmission.
3
Assess the position of the trachea.
The trachea is deviated to the right (the ipsilateral side).
Ipsilateral tracheal deviation signifies massive volume loss (atelectasis) pulling the mediastinum. Conversely, a large effusion or tension pneumothorax adds volume and pushes the mediastinum to the contralateral side.
4
Synthesize the physical examination findings into a single diagnosis.
The combination of ipsilateral tracheal deviation, dullness to percussion, decreased fremitus, and absent breath sounds points to complete endobronchial obstruction.
An obstruction (such as a bronchogenic carcinoma) prevents airflow, causing distal air to be resorbed. The lung collapses, resulting in significant volume loss that pulls the trachea toward the affected lung.

Key Concept

Differentiation of pulmonary pathology using the diagnostic constellation of percussion note, breath sounds, tactile fremitus, and tracheal deviation.
Question 3712Question →

A physician is reviewing charts for four adult patients who require targeted laboratory investigations to evaluate suspected endocrine etiologies for their clinical presentations. Select the single most appropriate initial diagnostic laboratory test to order for each specific patient scenario.

Click a left item, then click its matching right item

Items

A 42-year-old male with persistently elevated blood pressure of 165/98 mm Hg despite adherence to amlodipine and doxazosin. Routine basic metabolic panel reveals an unprovoked serum potassium level of 2.8 mEq/L.
A 38-year-old female intensive care unit nurse who works rotating night shifts. She presents with recent central adiposity, violaceous abdominal striae, and progressive proximal muscle weakness.
A 31-year-old female with a history of Hashimoto thyroiditis presenting with worsening fatigue, unintentional weight loss, and new-onset hyperpigmentation involving her buccal mucosa and palmar creases.
A 47-year-old male found to have a 3.5-centimeter lipid-poor adrenal mass on an unenhanced abdominal computed tomography scan performed for suspected nephrolithiasis. He also reports recent episodic palpitations and diaphoresis.

Matches

Show answer & explanation

Answer

The correct pairings map the hypertensive/hypokalemic male to aldosterone/renin ratio, the shift-working nurse with hypercortisolism signs to 24-hour urine free cortisol, the female with Addisonian features to morning cortisol/ACTH, and the male with an adrenal incidentaloma to plasma free metanephrines.
Each correct pairing reflects the gold-standard initial laboratory investigation for specific adrenal/endocrine disorders, factoring in crucial patient-specific variables that alter standard test selection. Identifying primary aldosteronism requires aldosterone and renin; diagnosing primary adrenal insufficiency requires concurrent baseline cortisol and ACTH; pheochromocytoma requires metanephrines. Most critically, while Cushing syndrome typically allows three initial screening options, this patient's occupational shift work specifically contraindicates late-night salivary testing, leaving 24-hour urine free cortisol as the superior choice.

Step-by-Step Solution

1
Analyze the first clinical presentation (hypertension with hypokalemia).
Identify suspicion for primary hyperaldosteronism.
Unprovoked hypokalemia in a hypertensive patient warrants immediate screening via aldosterone-to-renin ratio.
2
Analyze the second clinical presentation (Cushingoid features in a shift worker).
Select 24-hour urine free cortisol.
Shift workers have altered circadian rhythms, which causes false-positive results in late-night salivary cortisol tests, making urine collection or low-dose dexamethasone suppression necessary instead.
3
Analyze the third clinical presentation (hyperpigmentation and fatigue in autoimmune patient).
Select concurrent 8:00 AM serum cortisol and ACTH.
This presentation strongly suggests primary adrenal insufficiency. Measuring baseline paired morning hormones is the required initial diagnostic step.
4
Analyze the fourth clinical presentation (adrenal mass with episodic sympathetic symptoms).
Select plasma fractionated free metanephrines.
Incidentalomas must be worked up for hormone hypersecretion. The addition of palpitations and diaphoresis demands immediate rule-out of pheochromocytoma.

Key Concept

Selecting the appropriate initial endocrine screening tests based on patient-specific physiological factors and proper sequencing guidelines.
Estimated Time:2m 0s
Question 3713Question →

A 68-year-old man with a known history of advanced non-small cell lung cancer presents to the emergency department reporting severe, progressive thoracic back pain over the past week. Over the last 24 hours, he has developed profound weakness in both legs and states he has been unable to urinate since yesterday evening. His vital signs are stable. On observation, he is in significant discomfort and is unable to bear weight on his lower extremities.

Arrange the following diagnostic and therapeutic interventions in the most appropriate chronological sequence for managing this patient's acute oncologic emergency.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with a neurological exam to confirm clinical suspicion, followed immediately by empiric intravenous corticosteroids. Only after steroids are administered should an urgent whole-spine MRI be obtained, which then guides definitive decompression by a surgical or radiation oncology specialist.
The standard of care for suspected malignant spinal cord compression requires immediate administration of corticosteroids as soon as the clinical diagnosis is suspected via neurological examination. Corticosteroids decrease vasogenic edema and relieve pressure on the spinal cord. Imaging with a whole-spine MRI should follow steroid administration, not precede it. Once the MRI confirms the extent and location of the epidural metastasis, a neurosurgical or radiation oncology consultation is required to determine the best modality for definitive decompression.

Step-by-Step Solution

1
Perform a targeted neurological examination.
Establishes clinical suspicion of malignant spinal cord compression (MSCC).
Identifies the sensory level and motor deficits necessary to justify emergent empiric interventions.
2
Administer high-dose intravenous dexamethasone.
Reduces peritumoral vasogenic edema.
Must precede imaging to prevent irreversible neurologic ischemia and permanent paralysis.
3
Obtain a whole-spine MRI.
Delineates the exact anatomic level and extent of epidural compression.
Essential for confirming the diagnosis and planning definitive local therapy.
4
Consult neurosurgery or radiation oncology.
Initiates definitive decompression therapy.
Medical management with steroids is only temporizing; surgical or radiation interventions provide definitive tumor control.

Key Concept

In patients with suspected malignant spinal cord compression, empiric high-dose corticosteroids must be administered immediately upon clinical suspicion, prior to obtaining confirmatory imaging.
Question 3714Question →

A 21-year-old man presents to the emergency department 18 hours after intentionally ingesting an unknown but massive quantity of over-the-counter pain medication. He complains of mild nausea, diaphoresis, and anorexia. Laboratory studies reveal an aspartate aminotransferase (AST) of 1,250 U/L and an alanine aminotransferase (ALT) of 1,400 U/L. The patient is diagnosed with severe acetaminophen hepatotoxicity. Arrange the following biochemical and subcellular events in the correct chronological sequence that leads to this patient's hepatocellular injury.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with the saturation of phase II pathways, leading to CYP2E1 metabolism and NAPQI formation. This causes profound glutathione depletion, allowing NAPQI to covalently bind to macromolecules, which ultimately causes mitochondrial failure and hepatocyte necrosis.
Acetaminophen hepatotoxicity is a quintessential model of chemical cellular injury. Following a massive intentional overdose, the standard non-toxic hepatic phase II conjugation pathways (sulfation and glucuronidation) become rapidly saturated. As a direct consequence, the excess acetaminophen is shunted toward phase I metabolism via the cytochrome P450 enzyme system, most notably CYP2E1. This pathway oxidizes acetaminophen into N-acetyl-p-benzoquinone imine (NAPQI), an exceptionally reactive and toxic intermediate. Under normal conditions, NAPQI is quickly conjugated and neutralized by hepatic glutathione. However, the sheer volume of NAPQI generated during an overdose leads to a profound and rapid depletion of hepatocellular glutathione reserves. Once glutathione drops below approximately 30% of normal levels, free electrophilic NAPQI accumulates in the cytosol. This reactive molecule then covalently binds to various nucleophilic intracellular macromolecules, exhibiting a strong affinity for mitochondrial proteins. The resulting formation of NAPQI-protein adducts severely impairs the mitochondrial electron transport chain, culminating in severe oxidative stress, a collapse of ATP production, and opening of the mitochondrial permeability transition pore. This cascade of organelle failure produces irreversible cellular injury and subsequent centrilobular (Zone 3) hepatocyte necrosis, which correlates clinically with the massive release of transaminases (AST and ALT) into the patient's bloodstream.

Step-by-Step Solution

1
Identify the initial metabolic shift following overdose.
Phase II sulfation and glucuronidation pathways are saturated.
At therapeutic doses, most acetaminophen is safely conjugated. Massive doses overwhelm this capacity.
2
Determine the alternative metabolic route.
Shunting to the cytochrome P450 system occurs, producing NAPQI.
CYP2E1 becomes the primary pathway for the excess drug, generating the toxic electrophilic intermediate NAPQI.
3
Trace the cellular defense mechanism.
Hepatocellular glutathione reserves become depleted.
Glutathione is continuously consumed to neutralize NAPQI until the stores are critically exhausted.
4
Identify the mechanism of direct cellular injury.
Unconjugated NAPQI covalently binds to cellular macromolecules.
Without glutathione for detoxification, the reactive NAPQI attacks essential structural and functional cellular proteins.
5
Link the subcellular damage to the clinical outcome.
Mitochondrial dysfunction leads to centrilobular necrosis.
Protein adducts halt oxidative phosphorylation, causing irreversible ischemic-like damage and cell death, primarily in Zone 3 of the liver where CYP2E1 concentration is highest.

Key Concept

The chronological sequence of acetaminophen-induced toxic cellular injury revolves around the transition from safe phase II metabolism to CYP-mediated phase I toxicity and the exhaustion of intrinsic antioxidant defenses.
Question 3715Question →

A 68-year-old man is hospitalized for the management of native-valve infective endocarditis. Blood cultures obtained on admission grow methicillin-resistant *Staphylococcus aureus* (MRSA). The patient is started on intravenous vancomycin. On hospital day 5, repeat blood cultures remain positive, and the vancomycin minimum inhibitory concentration (MIC) for the isolate is reported as 2 mcg/mL. Following an infectious disease consultation, his antimicrobial regimen is changed to intravenous daptomycin. The patient's clinical status initially improves, and clearance of bacteremia is documented. However, on hospital day 24, he develops recurrent high-grade fevers and chills. Repeat blood cultures once again grow MRSA. Susceptibility testing of the new isolate demonstrates a daptomycin MIC of 8 mcg/mL, indicating resistance. Which of the following molecular changes most likely occurred in this organism to confer resistance to the current antibiotic?

Show answer & explanation

Answer: Addition of a basic amino acid to membrane phospholipids

Answer

Addition of a basic amino acid to membrane phospholipids
The correct answer accurately describes the mechanism of daptomycin resistance in Staphylococcus aureus. Daptomycin is a lipopeptide antibiotic that requires calcium to insert into the Gram-positive cell membrane. Resistance most frequently arises from a mutation in the mprF (multiple peptide resistance factor) gene. This mutation increases the synthesis of lysyl-phosphatidylglycerol by transferring the positively charged amino acid L-lysine to phosphatidylglycerol. The increased concentration of positively charged lipids on the outer leaflet of the cell membrane creates an electrostatic repulsion against the active daptomycin-calcium complex, thereby preventing its insertion and subsequent cell depolarization.

Step-by-Step Solution

1
Identify the patient's clinical scenario and the specific antimicrobial failure.
The patient developed recurrent MRSA bacteremia while on daptomycin therapy, and the new isolate is definitively resistant to daptomycin.
Establishing the specific drug failure focuses the inquiry on mechanisms of daptomycin resistance rather than baseline methicillin resistance.
2
Recall the mechanism of action of daptomycin.
Daptomycin is a cyclic lipopeptide that complexes with calcium to insert into the Gram-positive bacterial cell membrane, causing rapid depolarization and cell death.
Understanding the target (the cell membrane) is essential to deducing how the bacteria evade the drug.
3
Determine the specific molecular mechanism of daptomycin resistance in Staphylococcus aureus.
Resistance primarily occurs via mprF gene mutations, which upregulate the transfer of the basic (positively charged) amino acid lysine to membrane phosphatidylglycerol.
This molecular change increases the net positive charge of the cell envelope, electrostatically repelling the positively charged daptomycin-calcium complex.

Key Concept

Daptomycin resistance in Staphylococcus aureus is typically mediated by mprF gene mutations, which lead to the addition of lysine (a positively charged basic amino acid) to membrane phospholipids. This increases the net positive charge of the bacterial cell membrane, repelling the drug.
Question 3716Question →

Evaluate the unique environmental and occupational histories in the following patient scenarios. Match each specific historical profile to the most likely toxicologic diagnosis.

Click a left item, then click its matching right item

Items

An immigrant worker presents with pronounced intention tremor, emotional lability (erethism), and gingival inflammation; the occupational history involves artisanal gold refining using amalgam techniques.
An adult evaluated for severe episodic abdominal pain, constipation, and subjective weakness reveals a social history notable for regular consumption of homemade spirits fermented in repurposed automobile radiators.
A factory veteran is assessed for diffuse bone pain, pseudo-fractures, and new-onset proteinuria; the occupational history is significant for three decades of work in nickel-alkaline battery recycling and smelting.
A rural resident presents with stocking-glove sensorimotor neuropathy, transverse leukonychia (Mees lines), and palmar hyperkeratosis; residential history reveals lifelong consumption of untreated water from a shallow private well near an abandoned agricultural site.

Matches

Show answer & explanation

Answer

The correct matches align artisanal gold refining with elemental mercury, moonshine distillation in radiators with lead, alkaline battery recycling with cadmium, and untreated agricultural well water with arsenic.
Establishing a definitive diagnosis for heavy metal poisoning heavily relies on identifying the specific environmental or occupational exposure in the medical history. Each historical profile provides a distinct trigger (gold refining, moonshine radiators, battery recycling, agricultural well water) that pairs uniquely with its corresponding clinical toxidrome.

Step-by-Step Solution

1
Analyze the exposure history of the artisanal gold miner with tremor and emotional lability.
Matches elemental mercury toxicity.
Elemental mercury is used to form amalgams in gold mining, and chronic exposure produces classic neurological and psychiatric symptoms.
2
Evaluate the social history of homemade spirits from car radiators combined with abdominal colic.
Matches lead toxicity.
Old radiators contain lead solder, which leaches into acidic moonshine, causing classic lead colic and motor weakness.
3
Assess the occupational history of alkaline battery recycling linked to bone pain and proteinuria.
Matches cadmium toxicity.
Nickel-cadmium battery exposure leads to cadmium accumulation, which causes renal tubular necrosis and secondary osteomalacia.
4
Correlate the well water consumption near agricultural land with neuropathy and skin changes.
Matches arsenic toxicity.
Arsenic is a known well-water contaminant that produces hyperkeratosis, polyneuropathy, and transverse white nail lines.

Key Concept

Identifying specific heavy metal toxidromes based on characteristic occupational and environmental history.
Question 3717Question →

A 58-year-old man presents to the clinic with a two-month history of fatigue, unintentional weight loss of 66 kg (1313 lbs), and intermittent bright red blood per rectum. Vital signs show a temperature of 37.1∘37.1^\circ C (98.8∘98.8^\circ F), blood pressure of 135/82135/82 mm Hg, heart rate of 8888/min, and respiratory rate of 1414/min. Physical examination reveals conjunctival pallor and mild left lower quadrant abdominal tenderness without guarding or rebound. A screening colonoscopy reveals a large, partially obstructing, friable mass in the sigmoid colon. Biopsy confirms moderately differentiated invasive adenocarcinoma. Subsequent staging computed tomography (CT) demonstrates multiple hepatic metastases. Molecular profiling of the tumor tissue reveals a missense mutation in the *KRAS* gene at codon 1212. The oncology team discusses initiating a systemic chemotherapy regimen. Based on the molecular profiling results, they explicitly decide to omit a specific biologic targeted therapy from the patient's treatment plan. Which of the following best describes the molecular basis for this tumor's primary resistance to the withheld biologic agent?

Show answer & explanation

Answer: Constitutive activation of a downstream GTP-binding protein independent of cell-surface receptor modulation.

Answer

Constitutive activation of a downstream GTP-binding protein independent of cell-surface receptor modulation.
The withheld biologic agents in this scenario are Epidermal Growth Factor Receptor (EGFR) inhibitors (e.g., cetuximab, panitumumab). EGFR normally stimulates cellular proliferation through the downstream RAS-RAF-MEK-ERK signaling pathway. KRAS is a membrane-anchored GTP-binding protein (GTPase) that functions as a critical switch in this cascade, alternating between an inactive GDP-bound state and an active GTP-bound state. Missense mutations in the KRAS gene, most commonly at codons 12 or 13, impair the protein's intrinsic ability to hydrolyze GTP. Consequently, the KRAS protein remains permanently locked in its active, GTP-bound conformation. Because this constitutive activation occurs downstream of EGFR, the signaling pathway continues to drive tumor growth even if a monoclonal antibody successfully binds and blocks the extracellular domain of EGFR. Therefore, EGFR inhibitors offer no clinical benefit and are absolutely contraindicated in KRAS-mutated colorectal cancer.

Step-by-Step Solution

1
Analyze the clinical presentation and biopsy results.
The patient has metastatic colorectal adenocarcinoma with a confirmed somatic KRAS mutation at codon 12.
Identifying the specific tumor histology and genetic profile is essential for determining appropriate targeted therapies.
2
Identify the biologic therapy that is contraindicated or withheld based on this specific genetic mutation.
Epidermal Growth Factor Receptor (EGFR) inhibitors, such as cetuximab and panitumumab, are withheld.
Current oncologic guidelines contraindicate the use of EGFR inhibitors in patients whose colorectal tumors harbor KRAS or NRAS mutations due to primary resistance.
3
Determine the molecular function of KRAS within the targeted signaling pathway.
KRAS is a membrane-bound GTP-binding protein (GTPase) that acts as an intracellular transducer downstream of the cell-surface EGFR.
Understanding the normal biochemical role of KRAS explains how somatic mutations alter cellular signaling.
4
Correlate the KRAS mutation with the mechanism of primary resistance to EGFR inhibitors.
The mutation causes KRAS to lose its intrinsic GTPase activity, locking it in a constitutively active (GTP-bound) state. Because KRAS sits downstream of EGFR, it continues to drive cellular proliferation even if the upstream EGFR is blocked by a monoclonal antibody.
This confirms that the resistance is due to constitutive activation of a downstream GTP-binding protein, making upstream receptor blockade futile.

Key Concept

Epidermal Growth Factor Receptor (EGFR) inhibitors are ineffective in colorectal cancers with KRAS mutations because the mutated downstream GTP-binding protein (KRAS) remains constitutively active regardless of upstream receptor blockade.
Question 3718Question →

Match each patient's clinical presentation with the primary mechanism of action of the responsible bacterial toxin.

Click a left item, then click its matching right item

Items

A 6-year-old unimmunized boy presenting with a thick, grayish pharyngeal exudate and severe cervical lymphadenopathy.
A 35-year-old woman presenting with profound, watery diarrhea and severe dehydration after consuming undercooked seafood.
A 22-year-old man presenting with severe jaw stiffness and painful muscle spasms after sustaining a deep puncture wound.
A 4-year-old girl presenting with bloody diarrhea and new-onset oliguria following consumption of an undercooked hamburger.

Matches

Show answer & explanation

Answer

The unimmunized boy (diphtheria) matches with ADP-ribosylation of EF-2. The woman with watery diarrhea (cholera) matches with ADP-ribosylation of Gs alpha. The man with muscle spasms (tetanus) matches with cleavage of synaptobrevin. The girl with bloody diarrhea (EHEC) matches with inactivation of the 60S ribosomal subunit.
Each pathogen relies on a specific exotoxin to produce its characteristic clinical disease. Corynebacterium diphtheriae uses an A-B toxin to ADP-ribosylate EF-2. Vibrio cholerae uses an A-B toxin to ADP-ribosylate Gs alpha. Clostridium tetani produces a protease (tetanospasmin) that cleaves SNARE proteins. Enterohemorrhagic E. coli produces a Shiga-like toxin that inactivates the 60S ribosomal subunit.

Step-by-Step Solution

1
Analyze the first clinical vignette.
Identified Corynebacterium diphtheriae as the causative agent.
The unimmunized status, grayish pharyngeal pseudomembrane, and severe cervical lymphadenopathy (bull neck) are classic for diphtheria.
2
Determine the mechanism of diphtheria toxin.
Matched with ADP-ribosylation of EF-2.
Diphtheria toxin is an A-B exotoxin that halts cellular protein synthesis by inactivating elongation factor 2.
3
Analyze the second clinical vignette.
Identified Vibrio cholerae as the causative agent.
Profuse watery diarrhea after seafood consumption is the hallmark of cholera.
4
Determine the mechanism of cholera toxin.
Matched with ADP-ribosylation of the Gs alpha subunit.
Cholera toxin increases cAMP by permanently activating the stimulatory G-protein (Gs), leading to chloride and water efflux.
5
Analyze the third clinical vignette.
Identified Clostridium tetani as the causative agent.
Jaw stiffness (trismus) and muscle spasms following a puncture wound are characteristic of tetanus.
6
Determine the mechanism of tetanospasmin.
Matched with cleavage of synaptobrevin.
Tetanus toxin acts as a protease that cleaves SNARE proteins, blocking the release of inhibitory neurotransmitters and causing spastic paralysis.
7
Analyze the fourth clinical vignette.
Identified Enterohemorrhagic E. coli (EHEC) complicated by hemolytic uremic syndrome (HUS).
Bloody diarrhea followed by acute kidney injury in a child after eating undercooked beef is typical for EHEC.
8
Determine the mechanism of Shiga-like toxin.
Matched with inactivation of the 60S ribosomal subunit.
Shiga and Shiga-like toxins cleave host cell 28S rRNA (part of the 60S subunit), halting protein synthesis and causing cell death.

Key Concept

Bacterial exotoxins cause specific clinical syndromes through distinct intracellular mechanisms, such as inhibition of protein synthesis, overactivation of intracellular signaling pathways, or disruption of neurotransmitter release.
Question 3719Question →

Targeted biologic therapies are foundational in the management of severe rheumatologic, gastrointestinal, and dermatologic autoimmune diseases. The efficacy and safety profile of each agent are intrinsically linked to its specific immunopathologic target. Match each immunomodulating biologic agent with its precise molecular target in the inflammatory cascade.

Click a left item, then click its matching right item

Items

Adalimumab
Ustekinumab
Secukinumab
Tocilizumab
Abatacept

Matches

Show answer & explanation

Answer

Adalimumab binds to TNF-α\alpha. Ustekinumab binds to the p40 subunit of IL-12 and IL-23. Secukinumab binds to IL-17A. Tocilizumab binds to the IL-6 receptor. Abatacept binds to CD80/CD86 on antigen-presenting cells.
Each biologic agent targets a specific mechanistic node in the inflammatory cascade. Matching them correctly relies on understanding whether they neutralize a circulating cytokine (like Adalimumab, Secukinumab, and Ustekinumab), block a cytokine receptor (like Tocilizumab), or interfere with cellular co-stimulation (like Abatacept).

Step-by-Step Solution

1
Identify the primary mechanism of action for TNF inhibitors.
Adalimumab is recognized as a direct monoclonal antibody against TNF-α\alpha.
TNF-α\alpha is a central cytokine in rheumatoid arthritis and inflammatory bowel disease, which Adalimumab neutralizes.
2
Differentiate the interleukin inhibitors by their specific targets.
Ustekinumab targets IL-12/23 (p40 subunit), Secukinumab targets IL-17A, and Tocilizumab blocks the IL-6 receptor.
Recognizing specific interleukin pathways is necessary for appropriate biologic selection based on the patient's underlying condition (e.g., Secukinumab for ankylosing spondylitis, Ustekinumab for Crohn's/psoriasis, Tocilizumab for giant cell arteritis/rheumatoid arthritis).
3
Identify the mechanism of T-cell co-stimulation blockade.
Abatacept acts as a decoy receptor binding to CD80/CD86.
By binding CD80/CD86 on APCs, Abatacept prevents the 'Signal 2' via CD28 required for full T-cell activation.

Key Concept

The precise molecular targets of biologic disease-modifying antirheumatic drugs (DMARDs) dictate their clinical indications and adverse effect profiles.
Question 3720Question →

A 71-year-old woman is evaluated in the emergency department for dizziness, decreased urine output, and profound fatigue over the past three days. Her medical history is significant for hypertension, heart failure with reduced ejection fraction, type 2 diabetes mellitus, and osteoarthritis. Two weeks ago, she began taking over-the-counter naproxen for worsening knee pain. Her chronic home medications include lisinopril, furosemide, metoprolol succinate, and sitagliptin. Vital signs show a blood pressure of 98/60 mm Hg and a heart rate of 88/min. Laboratory studies reveal a blood urea nitrogen (BUN) of 56 mg/dL and a serum creatinine of 2.9 mg/dL. A basic metabolic panel one month ago showed a BUN of 18 mg/dL and a serum creatinine of 1.1 mg/dL. During the evaluation of this patient's medical history, which of the following reported medications should be identified as synergistically contributing to her acute kidney injury? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Naproxen; Lisinopril; Furosemide

Answer

The medications synergistically contributing to the acute kidney injury are naproxen, lisinopril, and furosemide.
The correct combination of medications involves three distinct mechanisms that synergistically reduce glomerular filtration rate (GFR). Furosemide induces a state of hypovolemia, reducing overall renal perfusion. In a hypovolemic state, the kidneys rely on prostaglandins to dilate the afferent arteriole and angiotensin II to constrict the efferent arteriole to maintain GFR. Naproxen (an NSAID) blocks prostaglandin synthesis, leading to uninhibited afferent vasoconstriction. Concurrently, lisinopril (an ACE inhibitor) blocks angiotensin II production, leading to efferent vasodilation. This combined loss of afferent dilation and efferent constriction, along with volume depletion, leads to a precipitous drop in glomerular hydrostatic pressure and subsequent acute kidney injury.

Step-by-Step Solution

1
Identify the primary clinical problem from the presentation.
The patient has developed acute kidney injury (AKI), evidenced by a significant rise in blood urea nitrogen and serum creatinine.
Establishing the primary diagnosis is required before determining the etiology.
2
Evaluate the patient's medication history for potential nephrotoxic or hemodynamically active agents.
The patient is taking naproxen, lisinopril, and furosemide.
A thorough medical history evaluation must identify drugs that can compromise renal function.
3
Analyze the synergistic mechanisms of the identified medications.
Furosemide causes volume depletion, naproxen causes afferent arteriolar vasoconstriction, and lisinopril causes efferent arteriolar vasodilation. Together, they severely compromise glomerular filtration pressure.
Understanding the combined pharmacokinetic and pharmacodynamic effects confirms the etiology of the AKI.

Key Concept

The synergistic effect of diuretics, NSAIDs, and ACE inhibitors or ARBs (often referred to as the 'triple whammy') can severely compromise renal hemodynamics and precipitate acute kidney injury.
PreviousPage 186 / 237Next